Stay updated on Pembrolizumab in Muscle-invasive Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Muscle-invasive Bladder Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Muscle-invasive Bladder Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedFooter revision label updated to v3.4.2 (from v3.4.1) on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedThe page shows a revision label updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check27 days agoChange DetectedA glossary toggle was added to the page, and QC/version metadata labels were updated to v3.4.0 (replacing v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page shows a revision update from v3.3.3 to v3.3.4, indicating a minor version change with no impact on core content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded a Locations section with Milan (Mi) and updated the page revision to v3.3.3. Removed the old Mi Locations and v3.3.2 revision.SummaryDifference0.2%

- Check92 days agoChange DetectedA note now states that PubMed publications are automatically filled for the study, and a revision tag 'Revision: v3.3.2' is added; the previous PubMed publication description has been removed.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Muscle-invasive Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Muscle-invasive Bladder Cancer Clinical Trial page.